Covid-19 infekcijas norise un ārstēšama HIV inficētiem pacientiem.
No Thumbnail Available
Date
2023
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Rīgas Stradiņa universitāte
Rīga Stradiņš University
Rīga Stradiņš University
Abstract
Šajā pētījumā noskaidroja COVID-19 infekcijas gaitas smaguma pakāpi HIV inficētiem
pacientiem, analizējot pacientu letālo iznākumu biežumu no COVID-19 remdesivira pielietošanas
rezultātus HIV inficētiem pacientiem, kas slimo ar COVID-19 infekciju un abpusējo pneimoniju.
Pētījuma rezultāti rāda, ka HIV saguma pakāne neietekmē COVID-19 gaitu, letalitātes
biežuma cēlonis nav atkarīgs no COVID-19 HIV inficetām personām. Remdesivira pielietošanas
rezultāts HIV inficētiem pacientiem ar COVID-19 infekciju un abpusējo pneimoniju uzrādija
pozitīvu rezultātu.
Iegūtie dati norāda, ka nepastāv pārliecinošu pierādījumu, kas norādītu, ka HIV inficētam
pacientiem ir lielāka iespēja saslimt ar COVID-19 infekciju.
In this study, determined the severity of the course of COVID-19 infection in HIV-infected patients by analyzing the mortality rate from COVID-19 as a result of the use of remdesivir in HIV-infected patients with COVID-19 infection and bilateral pneumonia. The results of the study show that the effect of the severe stage of HIV on the course of COVID-19, the fatality rate does not depend on COVID-19 in HIV-infected persons, and the result of the use of remdesivir in HIV-infected patients with COVID-19 infection and bilateral pneumonia showed a positive result. The obtained data indicate the susceptibility of HIV-infected patients to contract COVID19, just like the rest of the population through airborne transmission
In this study, determined the severity of the course of COVID-19 infection in HIV-infected patients by analyzing the mortality rate from COVID-19 as a result of the use of remdesivir in HIV-infected patients with COVID-19 infection and bilateral pneumonia. The results of the study show that the effect of the severe stage of HIV on the course of COVID-19, the fatality rate does not depend on COVID-19 in HIV-infected persons, and the result of the use of remdesivir in HIV-infected patients with COVID-19 infection and bilateral pneumonia showed a positive result. The obtained data indicate the susceptibility of HIV-infected patients to contract COVID19, just like the rest of the population through airborne transmission
Description
Klīniskā farmācija
Clinical Pharmacy
Veselības aprūpe
Health Care
Clinical Pharmacy
Veselības aprūpe
Health Care
Keywords
COVID-19 infekcija, HIV, remdesivīrs, abpusēja pneimonija, gaisa pilienuceļā., COVID-19 infection, HIV, remdesivir, bilateral pneumonia, airborne.